ILAE official report: a practical clinical definition of epilepsy
Researchers can access the Certificate of Analysis library directly through the Amino USA website, allowing independent verification before purchasing
Rosenstock J, Wysham C, Fras JP, et al Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
The pooled outcomes for tirzepatide showed a more significant positive impact in each individual lipid measure as compared to semaglutide in a population with similar baseline characteristics
If you notice pain in one part of your body when you run, dont try to push through the discomfort
Adults with type 2 diabetes have lower risks for death and major adverse cardiovascular and kidney events if they use tirzepatide compared with GLP-1 receptor agonists, according to observational data published in JAMA Network Open